EXPD
20
-3
PEP
29
-3
PGR
37
-10
ADP
62
-4
VIX
66
11
SBUX
45
-3
FFIV
62
-4
IVZ
30
-10
GLW
46
-3
SJM
9
-7
AXP
60
-7
AMT
24
-4
DVN
35
13
TSN
20
-2
MCO
61
-7
VFC
65
11
DUK
55
-4
SHW
33
-3
AMG
52
-2
FE
38
-6
EXPD
20
-3
PEP
29
-3
PGR
37
-10
ADP
62
-4
VIX
66
11
SBUX
45
-3
FFIV
62
-4
IVZ
30
-10
GLW
46
-3
SJM
9
-7
AXP
60
-7
AMT
24
-4
DVN
35
13
TSN
20
-2
MCO
61
-7
VFC
65
11
DUK
55
-4
SHW
33
-3
AMG
52
-2
FE
38
-6
Financhill
Back

Blackrock Munivest Fund II Vs. Crinetics Pharmaceuticals Industry Stock Comparison

Buy
60

MVT
Blackrock Munivest Fund II

Last Price:
$10.52
Seasonality Move:
-1.43%
Sell
2

CRNX
Crinetics Pharmaceuticals

Last Price:
$40.59
Seasonality Move:
-6.74%
Buy
60
Blackrock Munivest Fund II (MVT) is a Buy

Is Blackrock Munivest Fund II a Buy, Sell or Hold?

  • The current Blackrock Munivest Fund II [MVT] share price is $10.53. The Score for MVT is 60, which is 20% above its historic median score of 50, and infers lower risk than normal.
  • MVT is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
2
Crinetics Pharmaceuticals (CRNX) is a Sell

Is Crinetics Pharmaceuticals a Buy, Sell or Hold?

  • The current Crinetics Pharmaceuticals [CRNX] share price is $40.59. The Score for CRNX is 2, which is 96% below its historic median score of 50, and infers higher risk than normal.
  • CRNX is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.

MVT Stock Price Chart

What is Blackrock Munivest Fund II's stock price today?

  • The Blackrock Munivest Fund II share price today is $10.53
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and MVT is experiencing slight selling pressure.

CRNX Stock Price Chart

What is Crinetics Pharmaceuticals's stock price today?

  • The Crinetics Pharmaceuticals share price today is $40.59
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CRNX is experiencing selling pressure, which indicates risk of future bearish movement.

MVT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.09 Sell
Relative Strength Index (14 RSI): 38.55 Sell
Chaikin Money Flow: -29764 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (10.47 - 11.01) Sell
Bollinger Bands (100): (10.8 - 11.4) Sell

CRNX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -2.44 Sell
Relative Strength Index (14 RSI): 22.69 Sell
Chaikin Money Flow: -2576687 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (49.5 - 57.26) Sell
Bollinger Bands (100): (51.08 - 57.64) Sell

MVT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 10.62 Sell
20-day SMA: 10.64 Sell
50-day SMA: 10.88 Sell
200-day SMA: 10.95 Sell
8-day EMA: 10.61 Sell
20-day EMA: 10.68 Sell
50-day EMA: 10.85 Sell
200-day EMA: 10.92 Sell

CRNX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 49.44 Sell
20-day SMA: 52.35 Sell
50-day SMA: 55.3 Sell
200-day SMA: 51.01 Sell
8-day EMA: 48.54 Sell
20-day EMA: 51.52 Sell
50-day EMA: 53.69 Sell
200-day EMA: 49.87 Sell

Blackrock Munivest Fund II Earnings Growth & MVT Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Crinetics Pharmaceuticals Earnings Growth & CRNX Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.16 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.18 per share, and a decrease next year of $0.47 per share.

Blackrock Munivest Fund II Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Crinetics Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):